Ghaleb Amr M, McConnell Beth B, Nandan Mandayam O, Katz Jonathan P, Kaestner Klaus H, Yang Vincent W
Division of Digestive Diseases, Department of Medicine, and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30033, USA.
Cancer Res. 2007 Aug 1;67(15):7147-54. doi: 10.1158/0008-5472.CAN-07-1302.
The zinc finger transcription factor Krüppel-like factor 4 (KLF4) is frequently down-regulated in colorectal cancer. Previous studies showed that the expression of KLF4 was activated by the colorectal cancer tumor suppressor adenomatous polyposis coli (APC) and that KLF4 repressed the Wnt/beta-catenin pathway. Here, we examined whether KLF4 plays a role in modulating intestinal tumorigenesis by comparing the tumor burdens in mice heterozygous for the Apc(Min) allele (Apc(Min/+)) and those heterozygous for both the Apc(Min) and Klf4 alleles (Klf4(+/-)/Apc(Min/+)). Between 10 and 20 weeks of age, Klf4(+/-)/Apc(Min/+) mice developed, on average, 59% more intestinal adenomas than Apc(Min/+) mice (P < 0.0001). Immunohistochemical staining showed that Klf4 protein levels were lower in the normal-appearing intestinal tissues of Klf4(+/-)/Apc(Min/+) mice compared with wild-type, Klf4(+/-), or Apc(Min/+) mice. In contrast, the levels of beta-catenin and cyclin D1 were higher in the normal-appearing intestinal tissues of Klf4(+/-)/Apc(Min/+) mice compared with the other three genotypes. Klf4 levels were further decreased in adenomas from both Apc(Min/+) and Klf4(+/-)/Apc(Min/+) mice compared with their corresponding normal-appearing tissues. Reverse transcription-PCR showed an inverse correlation between adenoma size and Klf4 mRNA levels in both Klf4(+/-)/Apc(Min/+) and Apc(Min/+) mice. There was also a progressive loss of heterozygosity of the wild-type Apc allele in adenomas with increasing size from Klf4(+/-)/Apc(Min/+) and Apc(Min/+) mice. Results from this study show that KLF4 plays an important role in promoting the development of intestinal adenomas in the presence of Apc(Min) mutation.
锌指转录因子Krüppel样因子4(KLF4)在结直肠癌中常呈下调状态。先前的研究表明,KLF4的表达由结直肠癌肿瘤抑制因子腺瘤性息肉病基因(APC)激活,且KLF4可抑制Wnt/β - 连环蛋白信号通路。在此,我们通过比较Apc(Min)等位基因杂合子小鼠(Apc(Min/+))和Apc(Min)与Klf4等位基因均为杂合子的小鼠(Klf4(+/-)/Apc(Min/+))的肿瘤负荷,来研究KLF4在调节肠道肿瘤发生过程中是否发挥作用。在10至20周龄之间,Klf4(+/-)/Apc(Min/+)小鼠平均比Apc(Min/+)小鼠多发生59%的肠道腺瘤(P < 0.0001)。免疫组织化学染色显示,与野生型、Klf4(+/-)或Apc(Min/+)小鼠相比,Klf4(+/-)/Apc(Min/+)小鼠外观正常的肠道组织中Klf4蛋白水平较低。相反,与其他三种基因型相比,Klf4(+/-)/Apc(Min/+)小鼠外观正常的肠道组织中β - 连环蛋白和细胞周期蛋白D1的水平较高。与相应的外观正常组织相比,Apc(Min/+)和Klf4(+/-)/Apc(Min/+)小鼠腺瘤中的Klf4水平进一步降低。逆转录 - PCR显示,在Klf4(+/-)/Apc(Min/+)和Apc(Min/+)小鼠中,腺瘤大小与Klf4 mRNA水平呈负相关。随着Klf4(+/-)/Apc(Min/+)和Apc(Min/+)小鼠腺瘤大小的增加,野生型Apc等位基因的杂合性也逐渐丧失。本研究结果表明,在存在Apc(Min)突变的情况下,KLF4在促进肠道腺瘤的发展中起重要作用。